• Menveo is indicated for active immunization of children (from 2 years of
age), adolescents and adults at risk of exposure to Neisseria meningitidis
groups A, C, W135 and Y, to prevent invasive disease.
• The use of this
vaccine should be in accordance with official recommendations.
CALL US
0151 482 2850